{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T05:26:21Z","timestamp":1768973181534,"version":"3.49.0"},"reference-count":20,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"DOI":"10.3201\/eid1010.040335","type":"journal-article","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T19:30:05Z","timestamp":1332963005000},"page":"1812-1815","source":"Crossref","is-referenced-by-count":30,"title":["Disease Susceptibility to ST11 Complex Meningococci Bearing Serogroup C or W135 Polysaccharide Capsules, North America1"],"prefix":"10.3201","volume":"10","author":[{"given":"Andrew J.","family":"Pollard","sequence":"first","affiliation":[{"name":"University of Oxford, Oxford, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Ochnio","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margaret","family":"Ho","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Callaghan","sequence":"additional","affiliation":[{"name":"University of Oxford, Oxford, United Kingdom;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Bigham","sequence":"additional","affiliation":[{"name":"Canadian Blood Services, Vancouver, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Dobson","sequence":"additional","affiliation":[{"name":"University of British Columbia, Vancouver, Canada;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","published-online":{"date-parts":[[2004,10]]},"reference":[{"key":"key-10.3201\/eid1010.040335-201203280400-R1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4049\/jimmunol.7.1.1","article-title":"A study of the virulence of meningococci for man and of human susceptibility to meningococcic infection.","volume":"7","author":"Heist","year":"1922","journal-title":"J Immunol"},{"key":"key-10.3201\/eid1010.040335-201203280400-R2","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","article-title":"Human immunity to the meningococcus. II. Development of natural immunity.","volume":"129","author":"Goldschneider","year":"1969","journal-title":"J Exp Med"},{"key":"key-10.3201\/eid1010.040335-201203280400-R3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1001\/jama.1995.03520290042027","article-title":"The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992. Emergence of a virulent clone of Neisseria meningitidis.","volume":"273","author":"Whalen","year":"1995","journal-title":"JAMA"},{"key":"key-10.3201\/eid1010.040335-201203280400-R4","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1128\/CDLI.10.5.780-786.2003","article-title":"Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England.","volume":"10","author":"Andrews","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"key":"key-10.3201\/eid1010.040335-201203280400-R5","unstructured":"Chan M-S, Jolley K. Neisseria MLST home page [cited 9 Aug 2004]. Available from http:\/\/pubmlst.org\/neisseria"},{"key":"key-10.3201\/eid1010.040335-201203280400-R6","doi-asserted-by":"crossref","unstructured":"Borrow R, Carlone GM. Serogroup B and C bactericidal assays. In: Pollard AJ, Maiden MCJ, editors. Meningococcal vaccines. Totowa (NJ): Humana Press Inc.; 2001. p. 289\u2013304.","DOI":"10.1385\/1-59259-148-5:289"},{"key":"key-10.3201\/eid1010.040335-201203280400-R7","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1128\/IAI.69.3.1568-1573.2001","article-title":"Serological basis for use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of correlates of protection.","volume":"69","author":"Borrow","year":"2001","journal-title":"Infect Immun"},{"key":"key-10.3201\/eid1010.040335-201203280400-R8","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1046\/j.1440-1754.2001.00679.x","article-title":"Meningococcal disease and vaccination in North America.","volume":"37","author":"Pollard","year":"2001","journal-title":"J Paediatr Child Health"},{"key":"key-10.3201\/eid1010.040335-201203280400-R9","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1016\/S0264-410X(02)00630-8","article-title":"Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era.","volume":"21","author":"Trotter","year":"2003","journal-title":"Vaccine"},{"key":"key-10.3201\/eid1010.040335-201203280400-R10","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1086\/315352","article-title":"Lack of immunity in university students before an outbreak of serogroup C meningococcal infection.","volume":"181","author":"Jones","year":"2000","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040335-201203280400-R11","first-page":"169","article-title":"Meningococcal disease associated with the Haj\u2014update.","volume":"10","author":"Public Health Laboratory Service","year":"2000","journal-title":"Commun Dis Rep CDR Wkly"},{"key":"key-10.3201\/eid1010.040335-201203280400-R12","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1128\/JCM.40.3.1083-1084.2002","article-title":"Neisseria meningitidis serogroups W135 and A were equally prevalent among meningitis cases occurring at the end of the 2001 epidemics in Burkina Faso and Niger.","volume":"40","author":"Taha","year":"2002","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1010.040335-201203280400-R13","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/oxfordjournals.aje.a120854","article-title":"Prevalence of meningococcal serogroups and description of three new groups.","volume":"87","author":"Evans","year":"1968","journal-title":"Am J Epidemiol"},{"key":"key-10.3201\/eid1010.040335-201203280400-R14","doi-asserted-by":"crossref","first-page":"761","DOI":"10.3201\/eid0808.010422","article-title":"Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.","volume":"8","author":"Aguilera","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"key-10.3201\/eid1010.040335-201203280400-R15","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1016\/S0140-6736(02)07716-4","article-title":"W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001.","volume":"359","author":"Hahne","year":"2002","journal-title":"Lancet"},{"key":"key-10.3201\/eid1010.040335-201203280400-R16","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1086\/340414","article-title":"Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex.","volume":"185","author":"Mayer","year":"2002","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040335-201203280400-R17","first-page":"152","article-title":"Meningococcal disease, serogroup W135, Burkina Faso. Preliminary report, 2002.","volume":"77","author":"World Health Organization","year":"2002","journal-title":"Wkly Epidemiol Rec"},{"key":"key-10.3201\/eid1010.040335-201203280400-R18","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1128\/JCM.41.12.5783-5786.2003","article-title":"First report of capsule replacement among electrophoretic type 37 Neisseria meningitidis strains in Italy.","volume":"41","author":"Stefanelli","year":"2003","journal-title":"J Clin Microbiol"},{"key":"key-10.3201\/eid1010.040335-201203280400-R19","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/infdis\/167.6.1320","article-title":"Antigenic and epidemiologic properties of the ET-37 complex of Neisseria meningitidis.","volume":"167","author":"Wang","year":"1993","journal-title":"J Infect Dis"},{"key":"key-10.3201\/eid1010.040335-201203280400-R20","unstructured":"Vazquez J. Experiences with meningococcal vaccines. Paper presented at: European Society for Paediatric Infectious Disease, 2004; Tampere, Finland."}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/10\/10\/04-0335_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T02:50:56Z","timestamp":1732589456000},"score":1,"resource":{"primary":{"URL":"http:\/\/wwwnc.cdc.gov\/eid\/article\/10\/10\/04-0335_article.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10]]},"references-count":20,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2004,10]]}},"URL":"https:\/\/doi.org\/10.3201\/eid1010.040335","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10]]}}}